12:00 AM
May 19, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Menarini, Vivus sales and marketing update

In its 1Q14 earnings, Vivus disclosed that Menarini launched Spedra avanafil for erectile dysfunction in France, Germany, Italy and the U.K. in March and in Spain in April. The March launches triggered...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >